Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Biologics at Novartis
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Symptom overlap in anxiety and multiple sclerosis.
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.
CD4 cell response to interval therapy with natalizumab.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
[Vitamin D for prevention of diseases?].
Tocilizumab, MS, and NMOSD.
Current and future drugs for treatment of MS-associated bladder dysfunction.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.

Pages